Active	Status	Sponsor type	Region	Phase	Filter
4 Active 11 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Levin, Myron J
B-HASTE, NCT04249037: Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV	Terminated	4	10	US	bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF), Biktarvy, Standard initiation of antiretroviral therapy (ART), Standard of Care ART	University of Colorado, Denver, Gilead Sciences	HIV/AIDS	07/23	07/23
PROVENT, NCT04625725 / 2020-004356-16: Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. Detailed data from PROVENT trial for prevention of COVID- Apr 2022 - Apr 2022: Detailed data from PROVENT trial for prevention of COVID- Efficacy and safety data from PROVENT trial for prevention of COVID-19 Aug 2021 - Aug 2021: Efficacy and safety data from PROVENT trial for prevention of COVID-19	Completed	3	5197	Europe, US	AZD7442, Combination of 2mAbs(AZD8895 and AZD1061), Placebo	AstraZeneca, Iqvia Pty Ltd	COVID-19	08/22	12/23
NCT04128189: Shingrix in Renal Transplant Recipients	Recruiting	3	132	US	Shingrix	University of Colorado, Denver	Kidney Transplant Recipient Response to Shingrix Vaccine	01/26	09/26
Allo, NCT05775718: Shingrix in Recipients of geneic Transplants	Recruiting	2	55	US	Zoster Vaccine Recombinant, Shingrix	University of Colorado, Denver, GlaxoSmithKline	Bone Marrow Transplant, Stem Cell Transplant	05/25	12/30
Salbenblatt, Carol
No trials found